smq/directoryAn evolving quant resource archive
Paper / 2023SMQ / 174066100822463
Valuing Post-Revenue Biopharmaceutical Assets with Pfizer's Current Portfolio as a Case Study
time seriesResource overview

Valuing Post-Revenue Biopharmaceutical Assets with Pfizer's Current Portfolio as a Case Study

Paper2023

by Brian Hobbs, Michael Kane, Yiran Liu, Yixuan Liang, Yongzhuo Chen

Tags
time series

Continue on SelfMadeQuant

Understand this paper

Suggested foundations for financial time series. Specialist prerequisites vary by paper.

Before you read

Go further

Explore a related reading path